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the ED and subsequently admitted as inpatients were considered
as one encounter. Encounters with hypoglycemia were catego-
rized into 3 mutually exclusive groups: 1) encounters due to
hypoglycemia required a primary inpatient diagnosis or any ED
diagnosis of hypoglycemia (ICD-9-CM code 251.0, 251.1, or
251.2); 2) encounters in which patients presented with hypogly-
cemia (ie, ﬁrst lab blood glucose [BG] during the ﬁrst 24 hours in
the hospital < 70 mg/dL); and 3) encounters in which patients
developed hypoglycemia only after the ﬁrst 24 hours in the
hospital. Outcomes were total charges, length of stay, discharge
to a skilled nursing facility (SNF), and inpatient mortality.
Encounter types 2 and 3 were each compared with encounters
without hypoglycemia (ie, all BG values 70 mg/dL). Compari-
sons were adjusted for potential confounders (e.g., reasons for
hospitalization, comorbidities, propensity score for hypoglyce-
mia) using multivariate regression models. Hypoglycemia was
rarely used as a primary diagnosis. Of 519,317 encounters
(n = 215,922 diabetic patients), 732 (0.14%) had hypoglycemia
as the reason for the encounter, and most (91%) were ED only
without admission. However, in 8971 encounters (1.73%),
patients presented with hypoglycemia. In an additional 19,487
encounters (3.75%), patients developed hypoglycemia. All out-
comes for patients who developed hypoglycemia were signiﬁ-
cantly different than those for patients without hypoglycemia.
However, only charges and odds of discharge to a SNF were
signiﬁcantly associated with presentation with hypoglycemia.
The effect of hypoglycemia on outcomes depends on when
hypoglycemia is deﬁned and is more pronounced in patients who
developed hypoglycemia than in patients who presented with
hypoglycemia.
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OBJECTIVE: This study estimates the prevalence of type 2 dia-
betes (T2DM) in youth treated in a primary care setting. Pub-
lished prevalence estimates range from 0.2 to 1.5 per 1000,
varying by estimation population. This study also quantiﬁes the
association between T2DM and obesity and seeks to conﬁrm
clinical links that have been established between T2DM among
youth and obesity. METHODS: A cross-sectional analysis was
conducted in the General Electric Electronic Medical Record
(EMR) database in 2002 and 2006. The prevalence population
included youth aged 5 to 19 with continuous database activity
during the year. T2DM included two T2DM ICD-9 codes, one
T2DM ICD-9 code and a prescription for insulin, a prescrip-
tion for an oral antidiabetic agent, or two fasting blood glucose
levels 126 mg/dl during or prior to the estimation year,
without type 1 diabetes or polycystic ovary syndrome. Findings
were stratiﬁed by baseline BMI. The odds of developing T2DM
by BMI category were estimated by logistic regression.
RESULTS: The 2002 and 2006 prevalence populations
included 89,087 and 107,857 youth respectively. The preva-
lence of T2DM per 1000 was 2.20 in 2002 and 4.45 in 2006.
Of those with a baseline BMI reading, 8.0% and 9.4% were
obese (BMI > 30 kg/m2) in 2002 and 2006 respectively. T2DM
prevalence in the obese was 6.8 and 22.7 per 1000 in 2002 and
2006 respectively; age, gender and race adjusted odds of the
obese developing T2DM relative to the normal weight popula-
tion were 6.56 and 11.49 in 2002 and 2006 respectively
(P < 0.001 for both). CONCLUSION: Obesity substantially
increases T2DM risks. The prevalence of T2DM in a popula-
tion of youth routinely treated in a primary care setting is
higher than other recent estimates and increased dramatically in
a four year time frame. Additional research is warranted
to identify treatment trends and outcomes in youth with
T2DM.
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OBJECTIVE: The rate of heart disease is 1.5-fold greater among
Aboriginals compared to the general Canadian population. Risk
factors such as smoking, hypertension, dyslipidemia, obesity and
diabetes are also more prevalent. For example, type 2 diabetes is
3.6–5.3 times more prevalent among Aboriginals. Obesity is
relatively common in diabetes, contributing to poor diabetes
control and the development of its associated complications. It is
of interest to compare the prevalence of obesity among Aborigi-
nals with diabetes to all Canadians with diabetes. METHODS: A
MEDLINE search was conducted (1966–2007) using the follow-
ing MeSH terms: Indians—North American, Canada, diabetes
mellitus, obesity and body mass index (BMI). Population-based
studies reporting the proportion of Aboriginals with diabetes
that were overweight (e.g.25 kg/m2 for women,27 kg/m2 for
men) or obese (30 kg/m2) were retrieved. Prevalence estimates
of elevated BMIs for Canadians with diabetes were obtained
from the LCDC National Population Survey (1996–1997) and
the Ontario Diabetes Database (1996–1997; Ontario Health
Survey). RESULTS: Twenty-three studies were retrieved. Seven-
teen studies were excluded because either the patient populations
or deﬁnitions of obesity/overweight differed between studies.
Ranges of 76.2–86.5% of Aboriginals with diabetes were either
overweight or obese compared to 59.4% of all Canadians with
diabetes. Furthermore, 44.1–69.6% of Aboriginals with diabetes
were obese compared to 28.6% of all Ontarians with diabetes.
CONCLUSION: When compared with the general Canadian
population with diabetes, elevated BMI is more commonly
observed among Aboriginals with diabetes. These ﬁndings
suggest that obesity, as a risk factor for poor diabetes control and
heart disease, is not optimally managed within the Aboriginal
diabetes population and may pose a great burden to the Aborigi-
nal community. The precise impact of obesity and diabetes on the
health of Aboriginals warrants further research.
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OBJECTIVE: To estimate prevalence of hospitalizations in dia-
betic patients, to determine factors which inﬂuence hospitaliza-
tions attributable to diabetes, and to calculate length of stay
(LOS) using health insurance claims data. METHODS: This
retrospective cohort study used health insurance claims data
collected from three Catholic University Medical Centers in
South Korea. Type 2 diabetes patients were identiﬁed if patients
received treatment for diabetes (ICD-10 code of E11x) at least
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